Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 28 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 28 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Company Announcement: TREK 2000 INTERNATIONAL LTD

Singapore, April 28 -- TREK 2000 INTERNATIONAL LTD made the following announcement: Security Name: TREK 2000 INT'L LTD REPL::Annual General Meeting::Voluntary (https://links.sgx.com/1.0.0/corporate-... Read More


Singapore Company Announcement: CK HUTCHISON FINANCE (16) LIMITED

Singapore, April 28 -- CK HUTCHISON FINANCE (16) LIMITED made the following announcement: Security Name: CK HUTCHI EUR650M 2%N280406 General Announcement::EXTRAORDINARY GENERAL MEETING HELD ON 27 AP... Read More


Singapore Company Announcement: HEPTAMAX INTERNATIONAL LIMITED

Singapore, April 28 -- HEPTAMAX INTERNATIONAL LIMITED made the following announcement: Security Name: HEPTAMAX INTERNATIONAL LIMITED REPL::Annual General Meeting::Voluntary (https://links.sgx.com/1.... Read More


Singapore Company Announcement: CK HUTCHISON EUROPE FINANCE (21) LIMITED

Singapore, April 28 -- CK HUTCHISON EUROPE FINANCE (21) LIMITED made the following announcement: Security Name: MULTIPLE General Announcement::EXTRAORDINARY GENERAL MEETING HELD ON 27 APRIL 2026 - P... Read More


Singapore Company Announcement: INTRACO LIMITED

Singapore, April 28 -- INTRACO LIMITED made the following announcement: Security Name: INTRACO LIMITED Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE IN INT... Read More


Singapore Company Announcement: INTRACO LIMITED

Singapore, April 28 -- INTRACO LIMITED made the following announcement: Security Name: INTRACO LIMITED General Announcement::NOTICE OF TRANSFER AND USE OF TREASURY SHARES (https://links.sgx.com/1.0.... Read More